Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides
- PMID: 4977282
- PMCID: PMC2138651
- DOI: 10.1084/jem.129.6.1349
Human immunity to the meningococcus. 3. Preparation and immunochemical properties of the group A, group B, and group C meningococcal polysaccharides
Abstract
The group-specific polysaccharides of group A and group C meningococci have been isolated by a new procedure which employs the cationic detergent Cetavlon to precipitate these polysaccharides from the whole culture. The A and C polysaccharide prepared by this method are noteworthy because they are of high molecular weight. The main constituent of the A polysaccharide is N-acetyl, O-acetyl mannosamine phosphate; of the C polysaccharide N-acetyl, O-acetyl neuraminic acid. This purification procedure, when applied to cultures of group B organisms, yields a polysaccharide consisting primarily of N-acetyl neuraminic acid. A passive hemagglutination test developed to measure antibodies to the polysaccharides demonstrated the specificity of these antigens. Using a hemagglutination inhibition test, these antigens were again found to be group-specific, and this test could be used for serogrouping meningococcal isolates.
Similar articles
-
Bacillus pumilus polysaccharide cross-reactive with meningococcal group A polysaccharide.Infect Immun. 1976 Jun;13(6):1654-62. doi: 10.1128/iai.13.6.1654-1662.1976. Infect Immun. 1976. PMID: 184043 Free PMC article.
-
Immunologic response of man to group B meningococcal polysaccharide vaccines.J Infect Dis. 1972 Nov;126(5):514-21. doi: 10.1093/infdis/126.5.514. J Infect Dis. 1972. PMID: 4197754 Clinical Trial. No abstract available.
-
Modification of meningococcal polysaccharide antigens for use in passive hemagglutination tests.J Immunol. 1968 Oct;101(4):808-9. J Immunol. 1968. PMID: 4971477 No abstract available.
-
Development of polysaccharide vaccines for the prevention of meningococcal diseases.Monogr Allergy. 1975;9:245-58. Monogr Allergy. 1975. PMID: 804088 Review. No abstract available.
-
[Meningococcal antigens and methods for their isolation (review of the literature)].Zh Mikrobiol Epidemiol Immunobiol. 1973 Jul;50(7):32-7. Zh Mikrobiol Epidemiol Immunobiol. 1973. PMID: 4204663 Review. Russian. No abstract available.
Cited by
-
Effects of meningococcal and Escherichia coli capsular polysaccharides on human and dog platelet aggregation in vitro.J Clin Pathol. 1976 May;29(5):438-40. doi: 10.1136/jcp.29.5.438. J Clin Pathol. 1976. PMID: 819463 Free PMC article.
-
Human immunity to the meningococcus. II. Development of natural immunity.J Exp Med. 1969 Jun 1;129(6):1327-48. doi: 10.1084/jem.129.6.1327. J Exp Med. 1969. PMID: 4977281 Free PMC article.
-
Isolation of the capsular polysaccharide from culture supernatant of Haemophilus influenzae type b.Infect Immun. 1977 Feb;15(2):472-7. doi: 10.1128/iai.15.2.472-477.1977. Infect Immun. 1977. PMID: 300361 Free PMC article.
-
Serum antibody responses in Ethiopian meningitis patients infected with Neisseria meningitidis serogroup A sequence type 7.Clin Vaccine Immunol. 2007 Apr;14(4):451-63. doi: 10.1128/CVI.00008-07. Epub 2007 Feb 14. Clin Vaccine Immunol. 2007. PMID: 17301215 Free PMC article.
-
Molecular cloning and functional characterization of components of the capsule biosynthesis complex of Neisseria meningitidis serogroup A: toward in vitro vaccine production.J Biol Chem. 2014 Jul 11;289(28):19395-407. doi: 10.1074/jbc.M114.575142. Epub 2014 May 21. J Biol Chem. 2014. PMID: 24849599 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources